Merrimack Pharmaceuticals
MACK
#8930
Rank
โ‚น21.43 B
Marketcap
โ‚น1,449
Share price
0.00%
Change (1 day)
11.03%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2024 (TTM): โ‚น1,156

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น1,328. In 2016 the company made an earnings per share (EPS) of -โ‚น1,172 an increase over its 2015 EPS that were of -โ‚น1,265.

EPS history for Merrimack Pharmaceuticals from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)โ‚น1,156
2016-โ‚น1,172-7.35%
2015-โ‚น1,26565%
2014-โ‚น766.42-39.39%
2013-โ‚น1,265-54.01%
2012-โ‚น2,750

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น245.22-81.53%๐Ÿ‡ซ๐Ÿ‡ท France
Geron
GERN
-โ‚น10.54-100.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
-โ‚น181.07-113.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น80.47-106.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น1,56,804-11,909.16%๐Ÿ‡บ๐Ÿ‡ธ USA